Search clinical trials for: tocilizumab IV

Total 3653 results

Jarmo Oksi

Completed

COVID-19: Salvage TOcilizumab as a Rescue Measure (COVIDSTORM)

Covid19

Finland
Hoffmann-La Roche

Completed

A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid Arthritis

Rheumatoid Arthritis

France, Germany, Italy, Spain, United Kingdom, Hong Kong, United States, Colombia, Brazil, Canada, New Zealand, South Africa, Philippines, Russian Federation, Thailand, Singapore, Bulgaria, Mexico, Australia, Lithuania, Poland, Ar... and more
Marius Henriksen

Terminated

Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure (TOCIVID)

Corona Virus Disease

Denmark
University of Chicago

Active, not recruiting

Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19 (COVIDOSE-2)

COVID-19

United States
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France

Completed

TOward the Lowest Effective DOse of Abatacept or Tocilizumab (TOLEDO)

Rheumatoid Arthritis

France
Celltrion

Not yet recruiting

A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P47 in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis
Centre Hospitalier National d'Ophtalmologie des...
Roche Chugai

Recruiting

Efficacy of Tocilizumab for the Treatment of Acute AION Related to GCA (TOCIAION)

Giant Cell Arteritis | Optic Ischaemic Neuropathy

France
University of Chicago

Recruiting

Tocilizumab for Acute Chest Syndrome

Sickle Cell Disease | Acute Chest Syndrome

United States
Reade Rheumatology Research Institute
ZonMw: The Netherlands Organisation for Health Research and Development

Recruiting

Use of Tocilizumab Drug Levels to Optimize Treatment in RA (TODORA)

Rheumatoid Arthritis

Netherlands
Memorial Sloan Kettering Cancer Center

Terminated

Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection

COVID-19

United States
University of Chicago

Completed

Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis (COVIDOSE)

COVID-19

United States
Karadeniz Technical University

Completed

Effect of Tocilizumab on Intensive Care Patients With COVID-19 Pneumonia, a Retrospective Cohort Study

COVID-19 | Mortality | Critical Care | Tocilizumab

Turkey
Assistance Publique - Hôpitaux de Paris

Unknown

CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI) (CORIMUNO-TOC)

Corona Virus Infection

France
Università Politecnica delle Marche
Azienda Ospedaliera Ospedali Riuniti Marche Nord

Unknown

Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis

SARS Pneumonia

Italy
Hospital of Prato

Unknown

Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission.

Giant Cell Arteritis

Italy
Hoffmann-La Roche

Completed

A Study to Evaluate Tocilizumab Treatment in a Real-Life Setting

Rheumatoid Arthritis

Italy
Hoffmann-La Roche

Completed

A Study to Assess Efficacy With Respect to Clinical Improvement in Disease Activity and Safety of Tocilizumab in Patients Wtih Active Rheumatoid Arthritis.

Rheumatoid Arthritis

Germany
Hoffmann-La Roche

Completed

A Study of Administration of RoActemra/Actemra (Tocilizumab) by Auto-injector Vs. Pre-filled Syringe in Healthy Volunteers

Healthy Volunteer

France
Hoffmann-La Roche

Recruiting

A Study Evaluating Tocilizumab in Pediatric Patients Hospitalized With COVID-19

COVID-19

Germany, Spain, United States, Greece, France, Italy, Poland, Brazil, United Kingdom, Croatia, South Africa
Sun Yat-sen University

Withdrawn

Efficacy and Safety of Tocilizumab for TAO

Thyroid Associated Ophthalmopathy | Tocilizumab

China
Fundacion SEIMC-GESIDA
Roche Pharma AG; Dynamic Science S.L.

Completed

Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia

COVID-19

Spain
Hoffmann-La Roche

Completed

Local, Non-Interventional Study of RoActemra (Tocilizumab) in Poland (ACT-POL): First-Line Treatment in Routine Clinical Practice of Participants With Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

Poland
Hoffmann-La Roche

Completed

A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis

Indonesia
University of Oklahoma
Hoffmann-La Roche

No longer available

Request for Single Patient IND for Compassionate/Emergency Use of Tocilizumab

Juvenile Idiopathic Arthritis

United States
Hoffmann-La Roche

Active, not recruiting

Trial of Mosunetuzumab (BTCT4465A) as Consolidation Therapy in Participants With Diffuse Large B-Cell Lymphoma Following First-Line Immunochemotherapy and as Monotherapy or in Combination With Polatuzumab Vedotin in Elderly/Unfit Participants With Previously Untreated Diffuse Large B-Cell Lymphoma

Diffuse Large B-cell Lymphoma

United States, Israel, Spain, Korea, Republic of, Poland, Taiwan
M Abdur Rahim Medical College and Hospital
First Affiliated Hospital Xi'an Jiaotong University; Cox's Bazar 250 Bed District... and other collaborators

Completed

Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial

Covid19 | Covid-19 ARDS

Bangladesh
Hoffmann-La Roche

Recruiting

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma

Non-Hodgkin Lymphoma

United States, Israel, Italy, Spain, United Kingdom
Allegheny Singer Research Institute (also known...

Recruiting

Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer (RIOT2)

Malignant Ascites | Malignant Pleural Effusion

United States
Hoffmann-La Roche

Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered Mosunetuzumab to Participants With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

United States, Poland, Ukraine, Georgia, Moldova, Republic of
Children's Hospital of Philadelphia

Withdrawn

Tocilizumab and Hemophagocytic Lymphohistiocytosis (HLH)

Hemophagocytic Lymphohistiocytosis

United States
Children's Hospital of Eastern Ontario

Completed

Single Patient Study to Treat Relapsing Polychondritis With Tocilizumab

Relapsing Polychondritis

Canada
Beneficência Portuguesa de São Paulo
Federal University of São Paulo; Hospital Israelita Albert Einstein; Hospital... and other collaborators

Terminated

Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers (TOCIBRAS)

COVID | Cytokine Release Syndrome | SARS Pneumonia

Brazil
Hoffmann-La Roche

Completed

A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc) (focuSSced)

Systemic Sclerosis

Belgium, United Kingdom, Mexico, Poland, United States, Japan, Argentina, Netherlands, Canada, France, Lithuania, Germany, Spain, Bulgaria, Denmark, Greece, Hungary, Italy, Portugal, Puerto Rico, Romania, Switzerland
University of California, Los Angeles
Genentech, Inc.

Completed

Musculoskeletal Ultrasound in Predicting Early Dose Titration With Tocilizumab (RASTS)

Rheumatoid Arthritis

United States
NYU Langone Health
Genentech, Inc.

Terminated

Tocilizumab for the Treatment of Behcet's Syndrome

Behcet Syndrome

United States
Hoffmann-La Roche

Completed

A Non-interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Argentina
Hoffmann-La Roche

Completed

Efficacy and Safety Study of RoActemra (Tocilizumab) in Participants With Rheumatoid Arthritis

Rheumatoid Arthritis

Austria
Hoffmann-La Roche

Completed

An Open-label Study With Tocilizumab in Patients With Rheumatoid Arthritis in a Local Environment

Rheumatoid Arthritis

Tunisia
Chugai Pharmaceutical

Completed

PhaseⅢOpen-label Study of MRA for Rheumatoid Arthritis(RA)

Rheumatoid Arthritis

Japan
Peking Union Medical College Hospital

Recruiting

The Efficacy and Safety of Tocilizumab for Severe RP-ILD Secondary to Systemic Diseases

Rapid Progressive Interstitial Lung Diseases

China
Hospital Italiano de Buenos Aires

Recruiting

Safety and Effectiveness Study of Tocilizumab in Patients With Severe COVID-19

Tocilizumab | Severe COVID 19 Pneumonia

Argentina
Sciberras, Stephen M.D.
Mater Dei Hospital, Malta

Completed

The Effect of Tocilizumab on Procalcitonin and Other Biochemical and Clinical Markers in the Setting of COVID-19 Pneumonia

ARDS | COVID-19 Pneumonia

Malta
Centre Hospitalier Universitaire de Besancon

Completed

Evolution of Adipokines and Body Composition in Rheumatoid Arthritis Patients Receiving Tocilizumab Therapy (ADIPRAT)

Arthritis, Rheumatoid

France
UCB Pharma

Completed

Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy

Rheumatoid Arthritis

United States, Belgium, United Kingdom
Chugai Pharmaceutical

Recruiting

A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors

Solid Tumor

United States, Japan
Tang-Du Hospital

Recruiting

Open-Label Extension of Tocilizumab in Subjects With Generalized Myasthenia Gravis (tMG-E)

Myasthenia Gravis, Generalized

China
University of Colorado, Denver
National Cancer Institute (NCI)

Recruiting

Tocilizumab in Children With ACP

Adamantinomatous Craniopharyngioma

United States
National Cancer Institute, Naples

Active, not recruiting

Tocilizumab in COVID-19 Pneumonia (TOCIVID-19) (TOCIVID-19)

COVID-19 Pneumonia

Italy
Genentech, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia (EMPACTA)

COVID-19 Pneumonia

United States, Peru, Kenya, Mexico, Brazil, South Africa
Wenjie Zheng

Terminated

Tocilizumab for the Treatment of Refractory Behcet's Uveitis

Behcet Syndrome | Uveitis

China

Search clinical trials for: tocilizumab IV

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations